Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors

Daniel Fisher, Bin Xing, John Dill, Hui Li, Hai Hiep Hoang, Zhenze Zhao, Xiao Li Yang, Robert Bachoo, Stephen Cannon, Frank M. Longo, Morgan Sheng, Jerry Silver, Shuxin Li

Research output: Contribution to journalArticle

186 Citations (Scopus)

Abstract

Chondroitin sulfate proteoglycans (CSPGs) are a family of extra cellular matrix molecules with various functions in regulating tissue morphogenesis, cell division, and axon guidance. A number of CSPGs are highly upregulated by reactive glial scar tissues after injuries and forma strong barrier for axonal regeneration in the adult vertebrate CNS. Although CSPGs may negatively regulate axonal growth via binding and altering activity of other growth-regulating factors, the molecular mechanisms by which CSPGs restrict axonalelongationare not well understood. Here, we identified a novel receptor mechanism where byCSPGs inhibitaxonal growth via interactions with neuronal transmembrane leukocyte common antigen-related phosphatase(LAR).CSPGs bind LAR with high affinity in transfected COS-7cellsand coimmuno precipitate with LAR expressed in various tissues including the brain and spinal cord. CSPG stimulation enhances activity of LAR phosphatase in vitro. Deletion of LAR in knock-out mice or blockade of LAR with sequence-selective peptides significantly overcomes neurite growth restrictions of CSPGs in neuronal cultures. Intracellularly, CSPG-LAR interaction mediates axonal growth inhibition of neurons partially via inactivating Akt and activating RhoA signals. Systemic treatments with LAR-targeting peptides in mice with thoracic spinal cord transection injuries induce significant axon growth of descending serotonergic fibers in the vicinity of the lesion and beyond in the caudal spinal cord and promote locomotor functional recovery. Identification of LAR as a novel CSPG functional receptor provides a therapeutic basis for enhancing axonal regeneration and functional recovery after CNS injuries in adult mammals.

Original languageEnglish (US)
Pages (from-to)14051-14066
Number of pages16
JournalJournal of Neuroscience
Volume31
Issue number40
DOIs
StatePublished - Oct 5 2011

Fingerprint

CD45 Antigens
Chondroitin Sulfate Proteoglycans
Growth Inhibitors
Phosphoric Monoester Hydrolases
Axons
Class 2 Receptor-Like Protein Tyrosine Phosphatases
Growth
Spinal Cord Injuries
Regeneration
Spinal Cord
Peptides
Wounds and Injuries
Neurites
Morphogenesis
Knockout Mice
Neuroglia
Cell Division
Cicatrix
Vertebrates
Mammals

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors. / Fisher, Daniel; Xing, Bin; Dill, John; Li, Hui; Hoang, Hai Hiep; Zhao, Zhenze; Yang, Xiao Li; Bachoo, Robert; Cannon, Stephen; Longo, Frank M.; Sheng, Morgan; Silver, Jerry; Li, Shuxin.

In: Journal of Neuroscience, Vol. 31, No. 40, 05.10.2011, p. 14051-14066.

Research output: Contribution to journalArticle

Fisher, D, Xing, B, Dill, J, Li, H, Hoang, HH, Zhao, Z, Yang, XL, Bachoo, R, Cannon, S, Longo, FM, Sheng, M, Silver, J & Li, S 2011, 'Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors', Journal of Neuroscience, vol. 31, no. 40, pp. 14051-14066. https://doi.org/10.1523/JNEUROSCI.1737-11.2011
Fisher, Daniel ; Xing, Bin ; Dill, John ; Li, Hui ; Hoang, Hai Hiep ; Zhao, Zhenze ; Yang, Xiao Li ; Bachoo, Robert ; Cannon, Stephen ; Longo, Frank M. ; Sheng, Morgan ; Silver, Jerry ; Li, Shuxin. / Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors. In: Journal of Neuroscience. 2011 ; Vol. 31, No. 40. pp. 14051-14066.
@article{e9f65a9bab5d4aa9b4a25c1a4e535ddf,
title = "Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors",
abstract = "Chondroitin sulfate proteoglycans (CSPGs) are a family of extra cellular matrix molecules with various functions in regulating tissue morphogenesis, cell division, and axon guidance. A number of CSPGs are highly upregulated by reactive glial scar tissues after injuries and forma strong barrier for axonal regeneration in the adult vertebrate CNS. Although CSPGs may negatively regulate axonal growth via binding and altering activity of other growth-regulating factors, the molecular mechanisms by which CSPGs restrict axonalelongationare not well understood. Here, we identified a novel receptor mechanism where byCSPGs inhibitaxonal growth via interactions with neuronal transmembrane leukocyte common antigen-related phosphatase(LAR).CSPGs bind LAR with high affinity in transfected COS-7cellsand coimmuno precipitate with LAR expressed in various tissues including the brain and spinal cord. CSPG stimulation enhances activity of LAR phosphatase in vitro. Deletion of LAR in knock-out mice or blockade of LAR with sequence-selective peptides significantly overcomes neurite growth restrictions of CSPGs in neuronal cultures. Intracellularly, CSPG-LAR interaction mediates axonal growth inhibition of neurons partially via inactivating Akt and activating RhoA signals. Systemic treatments with LAR-targeting peptides in mice with thoracic spinal cord transection injuries induce significant axon growth of descending serotonergic fibers in the vicinity of the lesion and beyond in the caudal spinal cord and promote locomotor functional recovery. Identification of LAR as a novel CSPG functional receptor provides a therapeutic basis for enhancing axonal regeneration and functional recovery after CNS injuries in adult mammals.",
author = "Daniel Fisher and Bin Xing and John Dill and Hui Li and Hoang, {Hai Hiep} and Zhenze Zhao and Yang, {Xiao Li} and Robert Bachoo and Stephen Cannon and Longo, {Frank M.} and Morgan Sheng and Jerry Silver and Shuxin Li",
year = "2011",
month = "10",
day = "5",
doi = "10.1523/JNEUROSCI.1737-11.2011",
language = "English (US)",
volume = "31",
pages = "14051--14066",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "40",

}

TY - JOUR

T1 - Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors

AU - Fisher, Daniel

AU - Xing, Bin

AU - Dill, John

AU - Li, Hui

AU - Hoang, Hai Hiep

AU - Zhao, Zhenze

AU - Yang, Xiao Li

AU - Bachoo, Robert

AU - Cannon, Stephen

AU - Longo, Frank M.

AU - Sheng, Morgan

AU - Silver, Jerry

AU - Li, Shuxin

PY - 2011/10/5

Y1 - 2011/10/5

N2 - Chondroitin sulfate proteoglycans (CSPGs) are a family of extra cellular matrix molecules with various functions in regulating tissue morphogenesis, cell division, and axon guidance. A number of CSPGs are highly upregulated by reactive glial scar tissues after injuries and forma strong barrier for axonal regeneration in the adult vertebrate CNS. Although CSPGs may negatively regulate axonal growth via binding and altering activity of other growth-regulating factors, the molecular mechanisms by which CSPGs restrict axonalelongationare not well understood. Here, we identified a novel receptor mechanism where byCSPGs inhibitaxonal growth via interactions with neuronal transmembrane leukocyte common antigen-related phosphatase(LAR).CSPGs bind LAR with high affinity in transfected COS-7cellsand coimmuno precipitate with LAR expressed in various tissues including the brain and spinal cord. CSPG stimulation enhances activity of LAR phosphatase in vitro. Deletion of LAR in knock-out mice or blockade of LAR with sequence-selective peptides significantly overcomes neurite growth restrictions of CSPGs in neuronal cultures. Intracellularly, CSPG-LAR interaction mediates axonal growth inhibition of neurons partially via inactivating Akt and activating RhoA signals. Systemic treatments with LAR-targeting peptides in mice with thoracic spinal cord transection injuries induce significant axon growth of descending serotonergic fibers in the vicinity of the lesion and beyond in the caudal spinal cord and promote locomotor functional recovery. Identification of LAR as a novel CSPG functional receptor provides a therapeutic basis for enhancing axonal regeneration and functional recovery after CNS injuries in adult mammals.

AB - Chondroitin sulfate proteoglycans (CSPGs) are a family of extra cellular matrix molecules with various functions in regulating tissue morphogenesis, cell division, and axon guidance. A number of CSPGs are highly upregulated by reactive glial scar tissues after injuries and forma strong barrier for axonal regeneration in the adult vertebrate CNS. Although CSPGs may negatively regulate axonal growth via binding and altering activity of other growth-regulating factors, the molecular mechanisms by which CSPGs restrict axonalelongationare not well understood. Here, we identified a novel receptor mechanism where byCSPGs inhibitaxonal growth via interactions with neuronal transmembrane leukocyte common antigen-related phosphatase(LAR).CSPGs bind LAR with high affinity in transfected COS-7cellsand coimmuno precipitate with LAR expressed in various tissues including the brain and spinal cord. CSPG stimulation enhances activity of LAR phosphatase in vitro. Deletion of LAR in knock-out mice or blockade of LAR with sequence-selective peptides significantly overcomes neurite growth restrictions of CSPGs in neuronal cultures. Intracellularly, CSPG-LAR interaction mediates axonal growth inhibition of neurons partially via inactivating Akt and activating RhoA signals. Systemic treatments with LAR-targeting peptides in mice with thoracic spinal cord transection injuries induce significant axon growth of descending serotonergic fibers in the vicinity of the lesion and beyond in the caudal spinal cord and promote locomotor functional recovery. Identification of LAR as a novel CSPG functional receptor provides a therapeutic basis for enhancing axonal regeneration and functional recovery after CNS injuries in adult mammals.

UR - http://www.scopus.com/inward/record.url?scp=80053624921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053624921&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.1737-11.2011

DO - 10.1523/JNEUROSCI.1737-11.2011

M3 - Article

VL - 31

SP - 14051

EP - 14066

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 40

ER -